Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 203

1.

Comorbid attention deficit/hyperactivity disorder and substance use disorder: treatment considerations.

Klassen LJ, Bilkey TS, Katzman MA, Chokka P.

Curr Drug Abuse Rev. 2012 Sep;5(3):190-8. Review.

PMID:
22571450
[PubMed - indexed for MEDLINE]
2.

A qualitative review of issues arising in the use of psycho-stimulant medications in patients with ADHD and co-morbid substance use disorders.

Kollins SH.

Curr Med Res Opin. 2008 May;24(5):1345-57. doi: 10.1185/030079908X280707 . Epub 2008 Apr 1. Review.

PMID:
18384709
[PubMed - indexed for MEDLINE]
3.

Substance abuse in patients with attention-deficit hyperactivity disorder : therapeutic implications.

Schubiner H.

CNS Drugs. 2005;19(8):643-55. Review.

PMID:
16097847
[PubMed - indexed for MEDLINE]
4.

[Methylphenidate. Therapy option for adults with ADHD and comorbid substance use disorder?].

Paslakis G, Kiefer F, Diehl A, Alm B, Sobanski E.

Nervenarzt. 2010 Mar;81(3):277-88. doi: 10.1007/s00115-009-2916-9. Review. German.

PMID:
20108084
[PubMed - indexed for MEDLINE]
5.

Predictors of treatment response in adolescents with comorbid substance use disorder and attention-deficit/hyperactivity disorder.

Tamm L, Trello-Rishel K, Riggs P, Nakonezny PA, Acosta M, Bailey G, Winhusen T.

J Subst Abuse Treat. 2013 Feb;44(2):224-30. doi: 10.1016/j.jsat.2012.07.001. Epub 2012 Aug 11.

PMID:
22889694
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Diagnosis and treatment of attention-deficit/hyperactivity disorder in children and adolescents. Council on Scientific Affairs, American Medical Association.

Goldman LS, Genel M, Bezman RJ, Slanetz PJ.

JAMA. 1998 Apr 8;279(14):1100-7. Review.

PMID:
9546570
[PubMed - indexed for MEDLINE]
7.

Adolescent substance use in the multimodal treatment study of attention-deficit/hyperactivity disorder (ADHD) (MTA) as a function of childhood ADHD, random assignment to childhood treatments, and subsequent medication.

Molina BS, Hinshaw SP, Eugene Arnold L, Swanson JM, Pelham WE, Hechtman L, Hoza B, Epstein JN, Wigal T, Abikoff HB, Greenhill LL, Jensen PS, Wells KC, Vitiello B, Gibbons RD, Howard A, Houck PR, Hur K, Lu B, Marcus S; MTA Cooperative Group.

J Am Acad Child Adolesc Psychiatry. 2013 Mar;52(3):250-63. doi: 10.1016/j.jaac.2012.12.014. Epub 2013 Feb 8.

PMID:
23452682
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Managing attention-deficit/hyperactivity disorder in the presence of substance use disorder.

Upadhyaya HP.

J Clin Psychiatry. 2007;68 Suppl 11:23-30. Review.

PMID:
18307378
[PubMed - indexed for MEDLINE]
9.

A randomized crossover clinical study showing that methylphenidate-SODAS improves attention-deficit/hyperactivity disorder symptoms in adolescents with substance use disorder.

Szobot CM, Rohde LA, Katz B, Ruaro P, Schaefer T, Walcher M, Bukstein O, Pechansky F.

Braz J Med Biol Res. 2008 Mar;41(3):250-7. Epub 2008 Feb 20.

PMID:
18327433
[PubMed - indexed for MEDLINE]
Free Article
10.

Subjective effects, misuse, and adverse effects of osmotic-release methylphenidate treatment in adolescent substance abusers with attention-deficit/hyperactivity disorder.

Winhusen TM, Lewis DF, Riggs PD, Davies RD, Adler LA, Sonne S, Somoza EC.

J Child Adolesc Psychopharmacol. 2011 Oct;21(5):455-63. doi: 10.1089/cap.2011.0014.

PMID:
22040190
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

ADHD, stimulant treatment in childhood and subsequent substance abuse in adulthood - a naturalistic long-term follow-up study.

Dalsgaard S, Mortensen PB, Frydenberg M, Thomsen PH.

Addict Behav. 2014 Jan;39(1):325-8. doi: 10.1016/j.addbeh.2013.09.002. Epub 2013 Sep 10.

PMID:
24090624
[PubMed - indexed for MEDLINE]
12.

Does stimulant therapy of attention-deficit/hyperactivity disorder beget later substance abuse? A meta-analytic review of the literature.

Wilens TE, Faraone SV, Biederman J, Gunawardene S.

Pediatrics. 2003 Jan;111(1):179-85.

PMID:
12509574
[PubMed - indexed for MEDLINE]
13.

Attention deficit hyperactivity disorder and substance use disorders.

Szobot CM, Bukstein O.

Child Adolesc Psychiatr Clin N Am. 2008 Apr;17(2):309-23, viii. doi: 10.1016/j.chc.2007.11.003. Review.

PMID:
18295148
[PubMed - indexed for MEDLINE]
14.

Methylphenidate DAT binding in adolescents with Attention-Deficit/ Hyperactivity Disorder comorbid with Substance Use Disorder--a single photon emission computed tomography with [Tc(99m)]TRODAT-1 study.

Szobot CM, Shih MC, Schaefer T, JĂșnior N, Hoexter MQ, Fu YK, Pechansky F, Bressan RA, Rohde LA.

Neuroimage. 2008 Apr 15;40(3):1195-201. doi: 10.1016/j.neuroimage.2007.12.050. Epub 2008 Jan 10.

PMID:
18282769
[PubMed - indexed for MEDLINE]
15.

Substance abuse in patients with attention-deficit/hyperactivity disorder.

Bukstein O.

Medscape J Med. 2008 Jan 31;10(1):24. Review.

PMID:
18324334
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Psychosis in a cocaine-dependent patient with ADHD during treatment with methylphenidate.

Delavenne H, Duarte Garcia F, Lacoste J, Cortese S, Charles-Nicolas A, Ballon N.

Gen Hosp Psychiatry. 2013 Jul-Aug;35(4):451.e7-9. doi: 10.1016/j.genhosppsych.2012.05.010. Epub 2012 Jun 25.

PMID:
22739113
[PubMed - indexed for MEDLINE]
17.

When ADHD and substance use disorders intersect: relationship and treatment implications.

Wilens TE, Fusillo S.

Curr Psychiatry Rep. 2007 Oct;9(5):408-14. Review.

PMID:
17915081
[PubMed - indexed for MEDLINE]
18.

The adolescent outcome of children with attention deficit hyperactivity disorder treated with methylphenidate or methylphenidate combined with multimodal behaviour therapy: results of a naturalistic follow-up study.

van der Oord S, Prins PJ, Oosterlaan J, Emmelkamp PM.

Clin Psychol Psychother. 2012 May-Jun;19(3):270-8. doi: 10.1002/cpp.750. Epub 2011 Mar 14.

PMID:
21404369
[PubMed - indexed for MEDLINE]
19.

Attention-deficit/hyperactivity disorder and early-onset substance use disorders.

Wilson JJ, Levin FR.

J Child Adolesc Psychopharmacol. 2005 Oct;15(5):751-63. Review.

PMID:
16262592
[PubMed - indexed for MEDLINE]
20.

ADHD, substance use disorders, and psychostimulant treatment: current literature and treatment guidelines.

Kollins SH.

J Atten Disord. 2008 Sep;12(2):115-25. doi: 10.1177/1087054707311654. Epub 2008 Jan 11. Review.

PMID:
18192623
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk